<DOC>
	<DOCNO>NCT00164281</DOCNO>
	<brief_summary>This randomize , blind , two-arm comparative trial continue versus limit isoniazid ( INH ) tuberculosis ( TB ) preventive therapy HIV-infected adult Gaborone Francistown , Botswana . Subjects accrue two year follow minimum 36 month .</brief_summary>
	<brief_title>Study Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy HIV-infected Persons Botswana</brief_title>
	<detailed_description>Randomized , double blind , two-arm comparative trial continuous vs. limit isoniazid preventive therapy HIV-infected adult Gaborone Francistown , Botswana . Subjects accrue two year follow minimum 36 month .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>1 . HIVinfected 2 . Age &gt; =18 year 3 . Tuberculin skin test positive negative 4 . Laboratory : Hemoglobin ( Hgb ) &gt; 6.5 gm/dl ; Neutrophil count &gt; 1,000 cells/mm3 ; Platelets &gt; 75,000/mm3 ; AST ( SGOT ) &lt; 122 U/L ; Creatinine &lt; 1.5 mg/dl ; Beta HCG = negative 5 . Karnofsky performance status &gt; =60 6 . Signed informed consent 1 . History TB last 3 year current active TB 2 . History noncompliance chronic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>TB</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>INH</keyword>
	<keyword>Isoniazid</keyword>
	<keyword>Preventive therapy</keyword>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Botswana</keyword>
	<keyword>LTBI</keyword>
	<keyword>Latent TB Infection</keyword>
</DOC>